NEWS
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection.
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection.
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Sep 01, 2021 Notice Announcement of Website Renewal
- Nov 18, 2019 Notice 2019/11/18-21 Exhibit at MEDICA 2019
- Nov 12, 2018 Notice 2018/11/12-15 Exhibit at MEDICA 2018
- Jul 31, 2018 Notice 2018/7/31-8/2 Exhibit at 70th AACC
- Nov 13, 2017 Notice 2017/11/13-16 Exhibit at MEDICA 2017
We will accumulate technology and knowledge, and continue to develop and improve our products.
Investors News
Investors
